Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
A pharmacist notices something that might seem small at first: a customer who’s been picking up their blood pressure medication on the third Tuesday of every month for five years suddenly calls requesting a refill two weeks early, then a month later, the refill sits uncollected for another three weeks. When the same customer comes in looking confused about which medications they’re supposed to take, the pharmacist realizes these aren’t just administrative glitches—they’re behavioral changes that point to cognitive decline. Pharmacists occupy a unique position to catch these warning signs because they see patients far more frequently than doctors do, giving them an unmatched window into subtle shifts in how someone manages their medications and daily routines.
This article explores how pharmacists can become the first line of defense against undiagnosed dementia and early cognitive decline. Specifically, we’ll look at how changes in medication refill patterns and blister pack usage can signal that something’s wrong cognitively, what other observable behaviors pharmacists should watch for, what pharmacists can actually do when they suspect a problem, and why this early intervention matters more than most people realize. The stakes are significant: nearly half of people diagnosed with mild cognitive impairment will progress to Alzheimer’s disease within just three years, which makes early detection potentially life-changing.
Table of Contents
- Why Pharmacists Are Uniquely Positioned to Spot Cognitive Decline Before Anyone Else
- What Changes in Medication Refill Patterns Actually Mean
- Blister Packs and Punched-Out Medication: Reading What the Evidence Shows
- What Early Dementia Actually Looks Like From a Pharmacist’s Perspective
- The Adherence Crisis That Masks Underlying Cognitive Problems
- What a Pharmacist Can Actually Do When Suspicion Arises
- Why Early Detection Changes Everything for Patients and Families
- Conclusion
Why Pharmacists Are Uniquely Positioned to Spot Cognitive Decline Before Anyone Else
Pharmacists see patients between 1.5 and 10 times more frequently than primary care physicians, according to pharmacy practice research. This frequency matters enormously. A patient might see their doctor once or twice a year for routine checkups, but they pick up medications far more often—sometimes monthly, sometimes weekly. Over months and years, a pharmacist builds an intimate knowledge of a customer’s patterns, habits, and baseline behavior. When something shifts—when that reliable customer starts forgetting what they ordered, or their spouse begins coming in to pick up medication instead of them—the pharmacist notices. This observation advantage exists because pharmacists aren’t just dispensing pills; they’re interacting with patients during brief but consistent touchpoints. They see whether someone looks confused, hears whether someone’s speech sounds slower or more repetitive, and witnesses whether someone can remember what medications they’re already taking.
A primary care doctor might miss these gradual changes across a full year of infrequent visits. A pharmacist, seeing the same person every month, will catch the drift. This is especially true in independent or smaller pharmacy chains where pharmacists develop actual relationships with their regular customers. However, this potential isn’t automatic. Pharmacists need to be trained to recognize cognitive decline patterns and to act on them appropriately. A pharmacist who’s simply rushing through the day without paying attention to customer behavior won’t catch anything. The early detection benefit only works if pharmacists are intentionally watching for these patterns and have the confidence to raise concerns with customers and their doctors.
What Changes in Medication Refill Patterns Actually Mean
The most concrete indicator of cognitive decline is a sudden change in when someone requests medication refills. A customer who has consistently requested refills on the same schedule for years—the third Thursday of the month, always early mornings—suddenly requests a refill three weeks early. Two months later, they call wondering why they haven’t received their medication yet, not understanding that they never requested it. These aren’t small inconsistencies that could happen to anyone; they’re departures from established, reliable patterns that lasted for years. This specifically matters for dementia and mild cognitive impairment because managing medication timing requires several cognitive functions simultaneously: remembering how much medication is left, knowing what day you’re supposed to refill, keeping track of how many days the medication lasts, and following through with the actual phone call or pharmacy visit. When someone’s short-term memory begins to decline, this system falls apart. They might forget they just refilled it.
They might not notice that the blister pack still has medication remaining because they’ve forgotten how to track what they’ve taken. One important limitation to keep in mind: a single missed refill or an early request by itself doesn’t indicate dementia. people are busy and distracted. The key indicator is a *change from baseline*—a departure from the customer’s established pattern over years. If someone has always been sporadic with refills, then continuing to be sporadic tells you nothing. If someone has always been reliable and suddenly becomes disorganized, that’s when the concern rises. This is why long-term relationships between pharmacists and patients are so valuable.
Blister Packs and Punched-Out Medication: Reading What the Evidence Shows
Pharmacists also notice physical evidence of medication management struggles. Patients who use blister packs—those small plastic calendar organizers where each dose is pre-packaged by day and time—present clear visual evidence of whether they’re taking their medications correctly. A blister pack with pills punched out on the wrong dates, or holes punched randomly throughout the week, or packs that come back weeks later still full, all tell a story about what’s happening cognitively. Specifically, a customer might return a blister pack that hasn’t been opened at all, or one where only a few pills from random dates have been removed. Another might come in confused about whether they’ve already taken their morning medication, having punched out pills but not actually ingested them.
These patterns indicate that the person can physically access the medications but doesn’t remember taking them, or doesn’t understand the purpose of the organized schedule. For someone with intact cognition, a blister pack works beautifully—it removes the need to remember. For someone with early dementia, it sometimes makes the problem more visible because the pharmacist can actually see the evidence of confusion. However, there’s an important caveat: some people simply don’t use blister packs, and some insurance plans or pharmacies don’t offer them. Additionally, a single unpunched blister pack could mean the customer just didn’t take medications that week for any number of reasons. The significance of blister pack evidence only becomes clear when combined with other signs—the refill pattern changes, the customer’s confusion, their memory complaints, the physical and behavioral changes the pharmacist observes during interactions.
What Early Dementia Actually Looks Like From a Pharmacist’s Perspective
Beyond medication patterns, pharmacists should be alert to other early signs of cognitive decline that become visible during regular interactions. The most obvious is short-term memory loss—a customer asking the same question twice in a single conversation, forgetting what they just said they came in for, not remembering that the pharmacist just explained their medication to them. Equally important are subjective memory complaints: when a customer or their family member says things like “they’re having trouble remembering things lately” or “they seem more forgetful than usual.” Pharmacists should also watch for depressive feelings, increased drowsiness or confusion, difficulty recognizing familiar objects or people, and changes in speech—talking more slowly, repeating themselves, or seeming to search for words. A customer who’s always been sharp and talkative who suddenly becomes quiet and withdrawn, or vice versa, warrants attention. Difficulty with complex activities becomes visible too: a customer who used to manage their own prescriptions but now brings someone else to do it, or who seems confused about which medications treat what condition.
These observable behavioral changes have been documented in pharmacy practice literature as early indicators of cognitive impairment. The value of tracking these signs is that they accumulate. No single sign proves anything. A person can be forgetful one day and sharp the next. But when a pharmacist observes multiple signs in the same customer over weeks and months—refill pattern changes, memory complaints, behavioral shifts, speech changes, and medication management confusion all appearing together—the picture becomes much clearer. That’s when the concern becomes serious enough to warrant a conversation with the customer and potentially their doctor.
The Adherence Crisis That Masks Underlying Cognitive Problems
Understanding medication adherence patterns is crucial to interpreting what refill changes might mean. Between 25 and 50 percent of seniors struggle with medication adherence overall, which provides context for why someone might miss doses or request refills at irregular intervals. However, dementia and cognitive decline make this problem dramatically worse. Among patients specifically taking anti-dementia medications, the adherence crisis is stark: within the first year of treatment, 40.8 percent are non-adherent, 43.6 percent discontinue their medication entirely, and approximately 30 percent stop taking the medication within just 90 days of starting it. This high discontinuation rate isn’t primarily because the medications don’t work or cause side effects—it’s because remembering to take a medication consistently is cognitively demanding, and people with declining cognition simply cannot maintain that habit. They forget they started taking something.
They forget why they’re taking it. They don’t notice that they’ve run out. They get confused about the correct dose. This means that unusual refill patterns in someone taking dementia medication can actually be a sign that the medication itself is addressing a real, progressive problem that’s beyond their ability to self-manage. One critical limitation of using adherence patterns to detect cognitive decline: if someone is already diagnosed with dementia and already on treatment, their poor adherence is expected and doesn’t add new diagnostic information. The real value in observing refill pattern changes is catching people in the *earlier* stages—those with mild cognitive impairment or very early dementia before they have a diagnosis. For those patients, the adherence crisis can be the first visible sign that something’s cognitively wrong.
What a Pharmacist Can Actually Do When Suspicion Arises
When a pharmacist recognizes patterns that suggest cognitive decline, action items exist at multiple levels. First, pharmacists can conduct brief cognitive assessments in private pharmacy consultation areas. A simple conversation that includes a few memory questions and observation of whether the patient can recall their current medications and the reasons for taking them can provide valuable diagnostic information. More formal screening tools like the Montreal Cognitive Assessment (MoCA) exist and can be administered by trained pharmacists. Second, pharmacists should recommend alternative medication delivery forms that can compensate for cognitive challenges.
Instead of a regular bottle requiring daily decisions about medication management, a customer might benefit from liquids if swallowing pills becomes difficult, transdermal patches that deliver medication through the skin without daily action required, or injectable medications that eliminate daily dosing. These adaptations don’t treat the cognitive decline itself, but they remove barriers to adherence that cognitive decline creates. Finally, pharmacists should document their observations and communicate them appropriately. This typically means having a conversation with the customer first (unless doing so would be unsafe), then contacting their primary care physician or other healthcare providers with specific observations: “Your patient has shown consistent patterns of medication confusion and refill management challenges over recent months. I recommend cognitive screening.” A pharmacist’s observations, backed by months of patient interaction, carry weight in healthcare decisions—especially when paired with specific, documented examples rather than vague concerns.
Why Early Detection Changes Everything for Patients and Families
The urgency of early detection becomes clear when you consider the trajectory of cognitive decline. Among people diagnosed with mild cognitive impairment, approximately 40 percent will progress to Alzheimer’s disease within just 36 months. This means that early identification isn’t just about getting a diagnosis—it’s potentially about slowing decline, preserving function longer, and allowing patients and families to make informed decisions about their future care before crisis arrives.
With early detection, patients can access treatments that may slow decline, make lifestyle modifications that can extend cognitive function, inform their families so appropriate support can be arranged, and participate in care planning while they’re still cognitively able to do so. They can designate healthcare proxies, make advance care directives, and explore support resources while they’re still able to understand and choose them. The difference between catching cognitive decline at the “mild cognitive impairment” stage versus waiting until someone reaches moderate dementia is often the difference between maintained independence and crisis-driven care transitions.
Conclusion
A pharmacist who pays attention—who notices when reliable customers become disorganized, who observes physical and behavioral changes, who tracks refill pattern deviations from baseline—can become an early warning system for cognitive decline that doctors might miss for months or years. This role matters because pharmacists see patients more frequently than any other healthcare provider, and because medication management itself is a cognitive task that breaks down noticeably in early dementia. The patterns are there to see for anyone trained to look.
The question for the pharmacy profession and for patients is whether this potential gets realized. Early detection of cognitive decline can change trajectories—allowing interventions that slow decline, enabling families to prepare, and preserving patient autonomy in decision-making. A conversation between a pharmacist and a customer, followed by appropriate communication with their physician, costs nothing and takes minutes. The potential value of catching dementia early is measured in preserved years of independence and function.
You Might Also Like
- The Free Dementia Risk Assessment Available Online From the Alzheimer’s Association
- Why Reminiscence Therapy Using Old Photographs Is One of the Most Effective Dementia Interventions
- The Dementia Friendly Banking Initiative Where Banks Train Tellers to Spot Signs of Cognitive Decline
For more, see Alzheimer’s Association.
